HLA CLASS-II EXPRESSION IN UNINDUCIBLE HEPATOCARCINOMA CELLS AFTER TRANSFECTION OF AIR-1 GENE-PRODUCT CIITA - ACQUISITION OF ANTIGEN-PROCESSING AND PRESENTATION CAPACITY
S. Sartoris et al., HLA CLASS-II EXPRESSION IN UNINDUCIBLE HEPATOCARCINOMA CELLS AFTER TRANSFECTION OF AIR-1 GENE-PRODUCT CIITA - ACQUISITION OF ANTIGEN-PROCESSING AND PRESENTATION CAPACITY, The Journal of immunology (1950), 161(2), 1998, pp. 814-820
The AIR-1-encoded CIITA transcriptional activator is crucial for both
constitutive and IFN-gamma-induced MHC class II gene transcription. We
show here that the MHC class II negative phenotype of the human hepat
ocarcinoma cell lines Alexander and HepG2 remains unmodified after tre
atment with IFN-gamma, although MHC class I expression is up-modulated
. This correlates with absence of CIITA mature transcripts. Transfecti
on of an expressible CIITA cDNA in Alexander cells resulted in a very
high cell surface expression of all three human class II subsets, HLA-
DR, -DP and -DQ, indicating that normally observed induction of CIITA
expression by IFN-gamma is probably blocked, in the hepatocarcinoma ce
ll lines, at the level of CIITA transcription and not at the level of
IFN-gamma receptor binding and signal transduction mechanisms. To asse
ss whether MHC class II expression on CIITA-transfected Alexander cell
s could have functional relevance, we tested their capacity to present
antigenic peptides to an HLA-DR-restricted T cell line specific for a
peptide of Mycobacterium tuberculosis Ag85 protein. It was found that
the transfected cells could not only present the exogenously suppleme
nted peptide but also process Ag85 protein to generate the specific ep
itope recognized by the HLA-DR-restricted T cell line. Similar results
were obtained with CIITA-transfected CFPAC-1 pancreatic adenocarcinom
a cells, which differed from Alexander cells in that they were inducib
le by IFN-gamma. These results suggest new strategies to act on CIITA
for increasing the potential of a tumor cell to present putative tumor
Ags to the immune system.